OncoSec Medical Incorporated
Simbol: ONCS
NASDAQ
0.2772
USDTržna cena danes
-0.0457
Razmerje P/E
-0.0010
Razmerje PEG
1.65M
Kapaciteta MRK
- 0.00%
Donos DIV
OncoSec Medical Incorporated (ONCS) Finančni izkazi
Bilanca stanja
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 41.19 | 12.3 | 46 | 20.4 | |||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.net-receivables | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.inventory | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.other-current-assets | 10.25 | 2.9 | 3.2 | 2.5 | |||||||||||||||
balance-sheet.row.total-current-assets | 51.44 | 15.2 | 49.2 | 22.8 | |||||||||||||||
balance-sheet.row.property-plant-equipment-net | 17.97 | 5.6 | 6.4 | 6.8 | |||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.intangible-assets | 1.48 | 0.4 | 0.4 | 0 | |||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 1.48 | 0.4 | 0.4 | 0 | |||||||||||||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.other-non-current-assets | 2.29 | 0.6 | 0.3 | 0.3 | |||||||||||||||
balance-sheet.row.total-non-current-assets | 21.74 | 6.6 | 7.1 | 7.1 | |||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.total-assets | 73.18 | 21.9 | 56.3 | 29.9 | |||||||||||||||
balance-sheet.row.account-payables | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.short-term-debt | 6.22 | 2 | 2.1 | 1.5 | |||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.long-term-debt-total | 14.19 | 4.1 | 5.2 | 6.4 | |||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||
balance-sheet.row.other-current-liab | 19.24 | 4.6 | 5.9 | 8.2 | |||||||||||||||
balance-sheet.row.total-non-current-liabilities | 34.19 | 9.1 | 10.2 | 6.4 | |||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.capital-lease-obligations | 16.39 | 5.2 | 6.1 | 6.4 | |||||||||||||||
balance-sheet.row.total-liab | 59.65 | 15.8 | 18.2 | 16 | |||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.common-stock | 0.01 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.retained-earnings | -1158.6 | -286 | -251.8 | -206.6 | |||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 1.48 | 0.2 | -0.1 | 0 | |||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 1170.65 | 291.8 | 289.9 | 220.5 | |||||||||||||||
balance-sheet.row.total-stockholders-equity | 13.54 | 6.1 | 38.1 | 13.9 | |||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 73.18 | 21.9 | 56.3 | 29.9 | |||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.total-equity | 13.54 | 6.1 | 38.1 | 13.9 | |||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 73.18 | - | - | - | |||||||||||||||
Total Investments | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.total-debt | 20.41 | 6.2 | 7.3 | 7.8 | |||||||||||||||
balance-sheet.row.net-debt | -20.78 | -6.1 | -38.6 | -12.5 |
Izkaz denarnih tokov
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -29.39 | -34.2 | -45.2 | -42.3 | |||||||||||||||
cash-flows.row.depreciation-and-amortization | 0.94 | 1.1 | 1.1 | 1 | |||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | -0.8 | -0.1 | |||||||||||||||
cash-flows.row.stock-based-compensation | 1.28 | 1.6 | 5.1 | 3.5 | |||||||||||||||
cash-flows.row.change-in-working-capital | 2.05 | -1.2 | -2.5 | 3.8 | |||||||||||||||
cash-flows.row.account-receivables | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.inventory | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.account-payables | -1.38 | -1.4 | -2.6 | 3.6 | |||||||||||||||
cash-flows.row.other-working-capital | 3.43 | 0.2 | 0.1 | 0.2 | |||||||||||||||
cash-flows.row.other-non-cash-items | 0.12 | 0.6 | 0.5 | 0.9 | |||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -24.99 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -0.24 | -0.2 | -0.8 | 0 | |||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -0.26 | -0.2 | -0.8 | 0 | |||||||||||||||
cash-flows.row.debt-repayment | -1.15 | -1.3 | -0.6 | -0.1 | |||||||||||||||
cash-flows.row.common-stock-issued | 0.04 | 0 | 62.8 | 30 | |||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.other-financing-activites | 4.65 | 0.1 | 6 | -1.5 | |||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 3.54 | -1.2 | 68.2 | 28.4 | |||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -0.08 | -0.1 | 0 | 0 | |||||||||||||||
cash-flows.row.net-change-in-cash | -21.55 | -33.7 | 25.6 | -4.8 | |||||||||||||||
cash-flows.row.cash-at-end-of-period | 41.19 | 12.3 | 46 | 20.4 | |||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 62.74 | 46 | 20.4 | 25.1 | |||||||||||||||
cash-flows.row.operating-cash-flow | -24.99 | -32.1 | -41.8 | -33.1 | |||||||||||||||
cash-flows.row.capital-expenditure | -0.24 | -0.2 | -0.8 | 0 | |||||||||||||||
cash-flows.row.free-cash-flow | -25.24 | -32.4 | -42.6 | -33.1 |
Vrstica izkaza poslovnega izida
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 0 | 0 | 0 | |||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 0 | 0 | 0 | |||||||||||||||
income-statement-row.row.gross-profit | 0 | 0 | 0 | 0 | |||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||
income-statement-row.row.research-development | 21.77 | - | - | - | |||||||||||||||
income-statement-row.row.selling-general-administrative | 10.88 | - | - | - | |||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||
income-statement-row.row.other-expenses | 0.06 | 0 | 0 | 0.2 | |||||||||||||||
income-statement-row.row.operating-expenses | 32.65 | 37 | 48.4 | 43.4 | |||||||||||||||
income-statement-row.row.cost-and-expenses | 32.65 | 37 | 48.4 | 43.4 | |||||||||||||||
income-statement-row.row.interest-income | 0 | 0 | 0 | 0 | |||||||||||||||
income-statement-row.row.interest-expense | 0.05 | 0 | 0 | 0 | |||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||
income-statement-row.row.total-other-income-expensenet | -0.07 | -0.5 | 0.8 | 0.3 | |||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||
income-statement-row.row.other-operating-expenses | 0.06 | 0 | 0 | 0.2 | |||||||||||||||
income-statement-row.row.total-operating-expenses | -0.07 | -0.5 | 0.8 | 0.3 | |||||||||||||||
income-statement-row.row.interest-expense | 0.05 | 0 | 0 | 0 | |||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0.99 | 1.1 | 1.1 | 1.2 | |||||||||||||||
income-statement-row.row.ebitda-caps | -31.66 | - | - | - | |||||||||||||||
income-statement-row.row.operating-income | -32.65 | -37 | -48.4 | -43.4 | |||||||||||||||
income-statement-row.row.income-before-tax | -32.72 | -37.5 | -47.6 | -43.1 | |||||||||||||||
income-statement-row.row.income-tax-expense | -2.58 | -3.3 | -2.4 | -0.9 | |||||||||||||||
income-statement-row.row.net-income | -30.14 | -34.2 | -45.2 | -42.3 |
Pogosto zastavljeno vprašanje
Kaj je OncoSec Medical Incorporated (ONCS) skupna sredstva?
OncoSec Medical Incorporated (ONCS) skupna sredstva so 21878368.000.
Kakšen je letni prihodek podjetja?
Letni prihodki so N/A.
Kolikšna je stopnja dobička podjetja?
Dobiček podjetja je 0.000.
Kakšen je prosti denarni tok podjetja?
Prosti denarni tok je -4.923.
Kolikšna je neto stopnja dobička podjetja?
Čista stopnja dobička je 0.000.
Kolikšni so skupni prihodki podjetja?
Celotni prihodki so 0.000.
Kaj je OncoSec Medical Incorporated (ONCS) čisti dobiček (čisti dobiček)?
Čisti dobiček (čisti prihodek) je -34179634.000.
Kolikšen je skupni dolg podjetja?
Skupni dolg je 6174765.000.
Kolikšni so stroški poslovanja?
Stroški poslovanja so 37012062.000.
Kolikšno je število denarnih sredstev podjetja?
Denarna sredstva podjetja so 3683330.000.